| 2024-04-04 | -2.12 % |
|
| 2024-04-03 | +0.87 % |
|
| 2024-03-28 | +0.55 % |
|
| 2024-03-14 | +0.89 % |
|
| 2024-03-12 | +0.72 % |
|
| 2024-03-11 | -1.27 % |
|
| 2024-03-04 | +0.67 % |
- The article discusses the recent 0.67% increase in HCA Health Care (HCA) stock and highlights how the market leader in robotic surgery equipment, Intuitive Surgical (NASDAQ:ISRG), has experienced significant growth. The upward trend in ISRG stock is attributed to favorable updates from its clients, such as Universal Health Services (UHS) and HCA Healthcare, indicating an increase in capital spending and inpatient surgical volumes. This positive trend in the healthcare industry is seen as a boon for ISRG, potentially leading to higher sales of robotic surgery systems and equipment, contributing to the stock's rise.
- Summary: HCA Healthcare (HCA) stock rose by 0.67% after being recognized as one of the 2024 World’s Most Ethical Companies by Ethisphere due to its commitment to business integrity through robust ethics, compliance, and governance programs.
Reason for HCA Healthcare (HCA) stock going up: The stock likely rose because of the positive recognition and reputation gained by HCA Healthcare being recognized as one of the World’s Most Ethical Companies by Ethisphere for the 14th time, demonstrating the company's commitment to values, ethics, compliance, and governance practices, as well as its efforts in making a positive impact on patients, colleagues, and communities.
|
| 2024-02-29 | -0.12 % |
|
| 2024-02-28 | -0.62 % |
|
| 2024-02-27 | +0.26 % |
|
| 2024-02-26 | -0.68 % |
|
| 2024-02-22 | +0.39 % |
|
| 2024-02-20 | +0.01 % |
|
| 2024-02-15 | +0.73 % |
|
| 2024-02-13 | -1.81 % |
|
| 2024-02-08 | -0.59 % |
|
| 2024-02-07 | +0.15 % |
|
| 2024-02-06 | -1.22 % |
|
| 2024-02-05 | +0.39 % |
|
| 2024-02-02 | -1.67 % |
|
| 2024-01-31 | +1.1 % |
|
| 2024-01-30 | +5.18 % |
|
| 2024-01-26 | -0.91 % |
|
| 2024-01-25 | +2.54 % |
|
| 2024-01-22 | +0.19 % |
|
| 2024-01-19 | +1.04 % |
|
| 2024-01-08 | +2.05 % |
|
| 2023-12-21 | +2 % |
|
| 2023-12-19 | +0.75 % |
|
| 2023-12-18 | -1.19 % |
|
| 2023-12-13 | +2 % |
- Augmedix, a healthcare technology company, has announced a partnership with Google Cloud to integrate its MedLM technology into its ambient medical documentation products, which will improve the quality of medical note output and enable rapid expansion into more sub-specialties in 2024, leading to a 2.0% increase in HCA Healthcare's stock.
- The article discusses the recent approval of two CRISPR-based gene therapies for sickle cell disease by the FDA, with one therapy, Lyfgenia, developed by Bluebird Bio, facing challenges due to a higher price tag, a safety warning, and the denial of a priority review voucher (PRV). These factors caused Bluebird's stock price to drop, but the company remains confident in its plan to bring the therapy to market, citing its existing infrastructure and other revenue-generating gene therapies.
|
| 2023-12-11 | +1.74 % |
|
| 2023-12-08 | +1.41 % |
|
| 2023-12-06 | -0.05 % |
|
| 2023-12-05 | -1.8 % |
|
| 2023-11-22 | +1.79 % |
|
| 2023-11-21 | +0.06 % |
|
| 2023-11-13 | -1.22 % |
|
| 2023-11-09 | -1.72 % |
|
| 2023-11-01 | -0.34 % |
|
| 2023-10-24 | -4.49 % |
|
